News

Dublin, 4th to 7th October 2022 – Dr Mike Westby, Centauri’s Chief Scientific Officer, presented at the 2022 ESCMID/ASM Conference on Drug Development, which aims to meet the challenge of antimicrobial resistance.

The conference looked at new antibiotic developments and preventing antibiotic resistance. Dr Westby was invited to discuss the use of immuno therapies as an alternative to antibiotics to treat Gram-negative infections.

The ESCMID/ASM Conference is the world’s premier Clinical Microbiology & Infectious Diseases event and brings together experts from many fields, European countries and all continents to present their latest findings, guidelines and experiences.